首页|利益平衡视角下完善我国药品专利期限补偿制度的思考

利益平衡视角下完善我国药品专利期限补偿制度的思考

扫码查看
药品专利与公共健康息息相关,其中涉及的利益关系包含了原研药、仿制药与公共健康利益,在制度设计时需要维护各方主体间的利益平衡.药品专利期限补偿制度的引入能够激发我国药企进行新药研发的积极性,但考虑到专利保护期的延长会对药品可及性造成负面影响,应当将具体内容结合我国国情加以调整.在利益平衡原则指导下,完善我国药品专利期限补偿制度可包括明晰适合药品的范围、完善补偿期的监督机制以及增设"出口豁免"条款,从而促进我国医药产业的良性发展.
The Improvement of China's Pharmaceutical Patent Term Extension System from the Perspective of Interest Balance
Pharmaceutical patents are closely related to public health,which involves the interests of originator drugs,generic drugs and public health interests,in the design of the system needs to maintain a balance of interests among the main parties. The introduction of the pharmaceutical patent term extension system can stimulate the enthusiasm of China's pharmaceutical enterprises for new drug research,but considering that the extension of the patent protection period will have a negative impact on the accessibility of medicines,the specific content should be adjusted in combination with China's national conditions. Under the guidance of the principle of balance of interests,China's pharmaceutical patent term extension system can be improved on the following aspects,including clarifying the scope of eligible medicines,improving the supervision mechanism of the extension period,and adding the export exemption clause to promote the benign development of China's pharmaceutical industry.

pharmaceutical patent term extensioninterest balanceoriginal druggeneric drug

应梵

展开 >

浙江药科职业大学药商学院 浙江 宁波 315100

药品专利期限补偿 利益平衡 原研药 仿制药

2024

中国卫生经济
中国卫生经济学会,卫生部卫生经济研究所

中国卫生经济

CSTPCDCHSSCD北大核心
影响因子:1.524
ISSN:1003-0743
年,卷(期):2024.43(12)